AUS
NZ
UK
CA
USA
IND
Health
Can TG Therapeutics Redefine Biopharma Strategies?
March 19, 2025 01:30 AM PDT| By Team Kalkine MediaHighlights:,Raymond James Financial Inc. records a new investment in TG Therapeutics, Inc. (NASDAQ:TGTX).,Institutional investors account for a majority ownership of the company’s shares.,TG Therapeutics focuses on advanced treatments for B-cell medi...
Is Universal Health Services Transforming the Healthcare Arena?
March 19, 2025 01:19 AM PDT| By Team Kalkine MediaHighlights,Notable expansions in institutional participation during the latest reporting period,Shifts in perspectives from several financial entities toward the company,Consistent shareholder distributions and above-forecast earnings in a recent qua...
What Factors Are Shaping Repligen's Market Movements?
March 19, 2025 01:18 AM PDT| By Team Kalkine MediaHighlights,Victory Capital Management Inc. reduced its stake in Repligen Co. (NASDAQ:RGEN) by a notable percentage during the fourth quarter.,Institutional investors have adjusted their positions, with some increasing their shares significantly.,Exec...
Is ZimVie Evolving Amid Shifting Market Dynamics?
March 19, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights,Notable rise in short interest with a modest fraction of shares sold short.,Strong involvement from institutional financial entities and hedge funds dominates the ownership structure.,Stock performance exhibits fluctuating trends across a...
How Is Elanco Animal Health (NYSE:ELAN) Managing Its Growth Strategy?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Victory Capital Management expanded its holdings in Elanco Animal Health during the latest quarter.,Multiple institutions, including Atria Investments Inc. and Oppenheimer Asset Management Inc., adjusted their positions.,Elanco Animal Heal...
Is Penumbra, Inc. (NYSE:PEN) Gaining Momentum in the Healthcare Market?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors continue to expand their holdings in Penumbra, contributing to a high percentage of institutional ownership.,Penumbra maintains a strong market presence with a substantial market capitalization and a diverse portfol...
How Is GSK plc (NYSE:GSK) Managing Its Growth in the Healthcare Industry?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,GSK experienced an increase in short interest, reflecting market adjustments.,Institutional firms, including FMR LLC and Fisher Asset Management, expanded their holdings in GSK.,GSK operates as a global healthcare company specializing in v...
How Is Amicus Therapeutics (NASDAQ:FOLD) Navigating the Competitive Biotech Landscape?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Victory Capital Management reduced its holdings in Amicus Therapeutics during the fourth quarter.,Several institutional firms, including Wellington Management, increased their stakes in the company.,Amicus Therapeutics continues to focus o...
How Does Institutional Confidence Impact Alphatec Holdings (NASDAQ:ATEC)?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Atria Investments Inc. expanded its stake in Alphatec Holdings during the fourth quarter.,Institutional firms, including Bank of New York Mellon Corp, also adjusted their holdings.,Alphatec Holdings focuses on medical technology solutions,...
How Is MannKind Corporation (NASDAQ:MNKD) Innovating Diabetes Treatment Solutions?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Victory Capital Management significantly boosted its investment in MannKind Corporation during the fourth quarter.,Several institutional investors have shown strong interest, with large increases in their holdings.,MannKind Corporation foc...
Is Blueprint Medicines (NASDAQ:BPMC) Gaining Momentum in the Biotechnology Sector?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional firms, including Jones Financial Companies, have expanded their holdings in Applied Digital.,The company has shown strong growth in its latest market updates.,Applied Digital continues to strengthen its role in high-performan...
Is Nuvalent (NASDAQ:NUVL) Gaining Market Attention with Its Oncology Pipeline?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Victory capital management reduced its holdings in nuvalent during the fourth quarter,Stock performance fluctuated within a wide range over the past year,Nuvalent advances its clinical pipeline with targeted cancer therapies,Nuvalent’s Rol...
How Does Scholar Rock (NASDAQ:SRRK) Stand in the Biopharmaceutical Market?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Proficio Capital Partners LLC acquired a new stake in Scholar Rock Holding Co.,Institutional ownership remains strong, with hedge funds and firms holding a majority of shares.,Scholar Rock continues its focus on biopharmaceutical research...
Is Disc Medicine (NASDAQ:IRON) Gaining Institutional Confidence?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Cantor Fitzgerald revised its price target for Disc Medicine, reflecting a shift in market expectations.,Institutional investors have increased their holdings, signaling a growing interest in the company.,The company remains focused on dev...
How Is Mereo BioPharma (NASDAQ:MREO) Advancing in the Biopharmaceutical Sector?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Mereo BioPharma Group has received multiple ratings from leading research firms.,Institutional investors have shown strong engagement, establishing new positions.,Market performance reflects volatility, indicating shifts in investor sentim...
Is Harmony Biosciences (NASDAQ:HRMY) Poised for Continued Growth?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors have increased their stakes in Harmony Biosciences.,The company continues to develop treatments targeting neurological disorders.,Harmony Biosciences maintains a strong market presence with its key product, WAKIX.,H...
How Is STAAR Surgical (NASDAQ:STAA) Innovating in Ophthalmic Medical Devices?
March 19, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors continue adjusting their positions in STAAR Surgical, reflecting strategic interest.,The company focuses on implantable lenses for vision correction, maintaining a strong position in the medical instruments sector.,...
Is Zoetis’ Global Expansion Strengthening Its Competitive Position?
March 18, 2025 11:05 AM PDT| By Team Kalkine MediaIs Zoetis’ Global Expansion Strengthening Its Competitive Position?
Why Is Oscar Health’s Stock Trending Lower?
March 18, 2025 10:43 AM PDT| By Team Kalkine MediaWhy Is Oscar Health’s Stock Trending Lower?
Atria Investments Inc. has made a $288,000 investment in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN).
March 18, 2025 01:54 AM PDT| By Team Kalkine MediaHighlights,Atria Investments Inc acquired 7,978 shares of Supernus Pharmaceuticals, valued at $288,000.,Insiders sold 11,104 shares amounting to $440,263 over the past 90 days.,Supernus Pharmaceuticals focuses on central nervous system treatment prod...
